Skip Navigation LinksHome > June 19, 2013 - Volume 27 - Issue 10 > Transmitted drug resistance in French HIV-2-infected patient...
doi: 10.1097/QAD.0b013e32836207f3
Research Letters

Transmitted drug resistance in French HIV-2-infected patients

Charpentier, Charlottea; Visseaux, Benoita; Bénard, Antoineb; Peytavin, Gillesc; Damond, Florencea; Roy, Célineb; Taieb, Audreyb; Chêne, Genevièveb; Matheron, Sophied; Brun-Vézinet, Françoisea; Descamps, Dianea; the ANRS CO5 HIV-2 Cohort

Collapse Box


We report the first transmitted drug resistance survey study in HIV-2-infected patients living in France. The prevalence of transmitted drug resistance was 5.0% (95% confidence interval, 0.1–9.9) with mutations detected only in protease, not in reverse transcriptase. In this series, 10% of patients displayed X4/dual-mixed viruses. These findings classified the rate of transmitted drug resistance in the HIV-2 French Cohort as low prevalence.

© 2013 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics